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ABSTRACT
The dysregulation of genes in neurodevelopmental disorders that lead to social and cognitive phenotypes
is a complex, multilayered process involving both genetics and epigenetics. Parent-of-origin effects of
deletion and duplication of the 15q11-q13 locus leading to Angelman, Prader-Willi, and Dup15q
syndromes are due to imprinted genes, including UBE3A, which is maternally expressed exclusively in
neurons. UBE3A encodes a ubiquitin E3 ligase protein with multiple downstream targets, including
RING1B, which in turn monoubiquitinates histone variant H2A.Z. To understand the impact of neuronal
UBE3A levels on epigenome-wide marks of DNA methylation, histone variant H2A.Z positioning, active
H3K4me3 promoter marks, and gene expression, we took a multi-layered genomics approach. We
performed an siRNA knockdown of UBE3A in two human neuroblastoma cell lines, including parental SH-
SY5Y and the SH(15M) model of Dup15q. Genes differentially methylated across cells with differing UBE3A
levels were enriched for functions in gene regulation, DNA binding, and brain morphology. Importantly,
we found that altering UBE3A levels had a profound epigenetic effect on the methylation levels of up to
half of known imprinted genes. Genes with differential H2A.Z peaks in SH(15M) compared to SH-SY5Y
were enriched for ubiquitin and protease functions and associated with autism, hypoactivity, and energy
expenditure. Together, these results support a genome-wide epigenetic consequence of altered UBE3A
levels in neurons and suggest that UBE3A regulates an imprinted gene network involving DNA
methylation patterning and H2A.Z deposition.
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Introduction
Autism spectrum disorder (ASD) is a developmental disability
characterized by social and communication impairments and
repetitive behaviors with an estimated prevalence of 1 in 68.1
Causes of ASD vary immensely among those affected involving
a variety of genetic mutations as well as multiple environmental
risk factors.2–4 Adding to the complexity of ASD etiology, genes
with de novo variants are enriched for functions involving chro-
matin modification, developmental transcription factors, and
signal transduction pathways.5–7 Epigenetic marks, such as
DNA methylation and histone modifications, have also been
observed to be critically important to proper brain develop-
ment.8,9 Additionally, aberrant epigenetic regulation has been
observed at the interface of genetic and environmental risk
interactions implicated in ASD.10–12
Genomic imprinting, whereby expression of a subset of
mammalian genes are restrained to one parental allele, is a cen-
tral epigenetic inheritance pattern relevant to ASD. Presently,
imprinting is understood as a mechanism aimed at controlling
the amount of maternal resources allocated to the offspring
from conception to weaning.13 Imprinted genes are members
of various gene families corresponding to diverse biochemical
processes and are regulated by associated imprinting control
regions (ICRs), which exhibit parent-of-origin epigenetic modi-
fications that govern the imprinting of the locus.14 Some
imprinted genes have been observed to associate in an
imprinted genes network (IGN) that controls embryonic
growth and differentiation.15 Similar to regulation of ICRs,
IGN expression was observed to be mediated by an epigenetic
effect through recruitment of chromatin-modifying part-
ners.16,17 The realization that IGN genes are coordinately regu-
lated brings a new perspective that has not been previously
examined in neurodevelopment or the etiology of ASD.
The human neurodevelopmental 15q11.2-q13.3 locus is a
region of particular interest to the study of how epigenetics and
imprinting disorders lead to ASD. Deletions of the 15q11.2-q12
locus on the paternal or maternal allele are responsible for the
reciprocal disorders of Prader-Willi (PWS) or Angelman (AS)
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syndromes, respectively. In contrast, maternal duplications,
lead to chromosome 15q11.2-q13.3 maternal duplication
(Dup15q) syndrome, a genetic cause of ASD. UBE3A, which
encodes an E3 ubiquitin ligase, is the imprinted gene most likely
responsible for maternal-specific effects of 15q11.2-q13.3 dele-
tion or duplication disorders.18 UBE3A has known ubiquitin
ligase function targeting multiple proteins for degradation.19,20
However, it has also been shown to have transcriptional co-acti-
vator functions at steroid hormone receptors involving direct
binding to the transcription complex.21,22 UBE3A is localized in
cytosolic and nuclear compartments and at both the pre- and
post-synaptic locations and may play a diverse role in multiple
cellular and transcriptional events in neurodevelopment.23 The
role of deficient UBE3A levels in AS has been well established;
however, the pathogenic role of increased UBE3A levels in
Dup15q syndrome remains untested.
We previously showed that both Dup15q brain and a neuronal
cell culture model exhibit significant global DNA hypomethyla-
tion enriched over autism candidate genes impacting their tran-
scriptional stability.24 Dup15q is one of the most common CNVs
observed in ASD and is characterized by increased expression of
maternally expressed UBE3A.25–27 While the specific role of
UBE3A in the ASD phenotype of Dup15q syndrome is not cur-
rently known, we observed a link between UBE3A overexpression
and histone H2A.Z epigenetic modifications on genes with func-
tions at neuronal synapses, transcriptional regulation, and signal
transduction pathways.24 This suggests that UBE3A might influ-
ence neuronal maturation by directing chromatin patterning.
Additionally, we proposed a mechanism by which UBE3A regu-
lates H2A.Z monoubiquitination via degradation of RING1B, a
known UBE3A target. This interaction may explain the role
UBE3A plays in the observed hypomethylation of Dup15q.
In this study, we took a multi-layered genomics approach to
understand how UBE3A affects the epigenome in Dup15q and
Angelman syndromes. Integrating whole genome bisulfite
sequencing (WGBS), transcriptome sequencing (RNA-seq), and
chromatin immunoprecipitation sequencing (ChIP-seq), we
developed an epigenomic profile of the dysregulation caused by
aberrant levels of UBE3A in human neuronal cell culture mod-
els. We observed strong overlap between genes with differentially
methylated regions (DMRs) and histone peaks of H3K4me3 and
H2A.Z. These UBE3A-altered genes were enriched for imprinted
genes with alterations to H2A.Z gene body localization.
Results
To understand the role of UBE3A in epigenetic regulation
genome-wide, we first performed triplicate siRNA knockdowns
of UBE3A (siUBE3A) or control (siCTL) in a human neuronal
cell line (SH-SY5Y) and a chromosome duplication model of
Dup15q syndrome [SH(15M)].28 Compared to the parental
SH-SY5Y cells treated with siCTL, UBE3A protein levels in
similarly treated SH(15M) cells were 30% higher, while cells
treated with siUBE3A were 90% lower in SH-SY5Y and 70%
lower in SH(15M) (Fig. 1A). Compared to the siCTL of each
parental cell line, knockdown efficiency of UBE3A was 90% in
SH-SY5Y and 72% in SH(15M) (Fig. S1A). From these cell cul-
tures, we isolated DNA for WGBS, RNA for RNA-seq, and
chromatin for ChIP-seq of one histone mark of active pro-
moters (H3K4me3) and one histone variant (H2A.Z) of active
promoters and poised genes (Fig. 1B). From each dataset, we
identified whole-genome methylation levels, differentially
expressed genes, and histone peaks, respectively.
Four comparison groups were created to explore the conse-
quences of UBE3A gain or loss within a different genomic con-
text (Fig. 1A). These included: 1) the chromosome 15M effect
(chr15M)(CTL-15M vs. CTL-SH); 2) reduced UBE3A in the
context of normal 2X copy number (KDSH)(KD-SH vs. CTL-
SH); 3) reduced UBE3A in the context of the 3X copy number
(KD15M)(KD-15M vs. CTL-15M); and 4) the 15M effect with
Figure 1. Multi-layered genomics analysis of SH-SY5Y and SH(15M) UBE3A siRNA knockdown reveals how altered UBE3A levels impact epigenomic patterns. (A) UBE3A
protein levels quantified from Western blot in SH(15M) and SH-SY5Y for siRNA control and UBE3A knockdown relative to GAPDH (blot in Fig. S1). Labeled are the four
comparison groups used for differential genomic analyses. Error bars represent the mean § SEM of three replicates. Significance by 2-way ANOVA P < 0.0001. (B) Study
design: following UBE3A siRNA knockdown and control treatment, each triplicate culture was harvested for DNA, RNA, or chromatin to assay DNA methylation, differen-
tially expressed genes, or histone peaks, respectively. (C) Table outlining results of the genomic assays for each comparison group by UBE3A levels. Each of the four com-
parisons generated independent lists of genes that overlapped with differential marks from each of the genomic assays.
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reduced UBE3A (chr15M-minus)(KD-15M vs. CTL-SH).
These comparisons were performed on each genomic data set
resulting in gene lists showing differentially methylated regions
(DMR genes) (D%methylation  0.1, q < 0.01), differential
expression (RNA genes) (P < 0.05), and differential histone
peak levels (K4me3 or H2A.Z genes) (q < 0.01) (Fig. 1C and
S3-S4). Across all comparisons, genes with DMRs were the
most numerous, while genes showing differential H2A.Z peaks
were least prevalent. Increase of UBE3A from the chromosome
15M effect showed the fewest differentially expressed genes
compared to the three knockdown comparisons. There were
distinctions between cell lines as knockdown of UBE3A in SH-
SY5Y had a profound effect on the levels of H3K4me3 peaks in
contrast to SH(15M), which had relatively few H3K4me3 peak
differences following knockdown.
To examine the convergent effect of UBE3A expression dif-
ferences, we determined the level of overlap between each data-
set within each comparison group and calculated significance
by Fisher’s exact test (Table 1). For all four comparisons, genes
with DMRs significantly overlapped genes with differential
H3K4me3 and H2A.Z peaks. Differentially expressed genes did
not significantly overlap with other datasets except in the
KDSH comparison group, where it overlapped with differential
H2A.Z genes. Genes with differential histone peaks H3K4me3
and H2A.Z overlapped in all comparisons except KD15M. All
comparisons except KDSH showed similar patterns of overlap
among all datasets, although KD15M comparison had relatively
fewer differential H3K4me3 peaks (Fig. 2 and S2). The KDSH
comparison showed the most unique pattern of overlapping
epigenetic marks displaying a large overlap of DMR,
H3K4me3, and H2A.Z associated genes, as well as a much
greater number of differential H3K4me3 peaks.
To identify UBE3A-impacted pathways, functions, and
traits, gene lists for each comparison group and dataset were
analyzed by Gene Ontology (GO) analysis. DMR analysis
showed a high enrichment for gene functions in DNA binding,
RNA metabolism, and regulation of gene expression across all
comparison groups (Fig. 3A). There was also strong enrich-
ment of neurologically relevant terms including brain morphol-
ogy and synaptic activity via the SNARE complex. Additionally,
terms consistent with neurodevelopmental disorder physical
characteristics, including broad face, waddling gait, and Genu
recurvatum, were enriched in the chr15M and KDSH groups.
Enrichment of DNA binding, chromatin, and gene expression
function were also seen for genes with differential H3K4me3
peaks within the chr15M and chr15M-minus groups (Fig. 3B).
These two comparison groups derived from SH(15M) cells
were also enriched for genes associated with impaired passive
avoidance and fear-related response behavioral phenotypes. No
significant enrichment was observed for the KD15M group.
The KDSH group, which showed the largest effect on differen-
tial H3K4me3 peaks, also had the most unique GO term
enrichment, with genes strongly enriched in epigenetic regula-
tion including the PRC1 and polycomb complexes.
Differentially expressed genes showed a separation of GO
term enrichments between gain and loss of UBE3A (Fig. 3C).
The chr15M comparison was uniquely enriched for genes
involved in glial and neuronal cell development. The three
UBE3A knockdown comparison groups had a large term over-
lap including regulation of translation, excitatory synapse,
Spt-Ada-Gcn5-acetyltransferase (SAGA-type) complex, and
abnormal imprinting. Genes from the abnormal imprinting
term included imprinted X-linked genes XIST and TSIX as well
as imprinted autosomal genes KCNQ10T1, IGF2, GNAS, and
PEG3 (Supplemental Data and Figures S5-S8).
While not all group comparisons showed significant GO
term enrichment for genes with differential H2A.Z peaks, theTable 1. Genomic datasets gene list overlaps.
Dataset 1 #Genes Dataset 2 #Genes Overlap Expected P value
chr15M Dataset Gene Overlaps
DMR 9778 RNA 962 412 443 0.98
DMR 9778 K4me3 1509 1188 696 3.2E-159
DMR 9778 H2A.Z 406 291 187 6.10E-26
RNA 962 K4me3 1509 69 68 0.49
RNA 962 H2A.Z 406 13 18 0.93
K4me3 1509 H2A.Z 406 146 29 5.80E-65
KDSH Dataset Gene Overlaps
DMR 7602 RNA 2557 762 917 1
DMR 7602 K4me3 14457 6926 5185 0.00EC00
DMR 7602 H2A.Z 24 15 8 7.10E-03
RNA 2557 K4me3 14457 1440 1744 1
RNA 2557 H2A.Z 24 7 3 0.02
K4me3 14457 H2A.Z 24 22 16 7.40E-03
KD15M Dataset Gene Overlaps
DMR 5126 RNA 2947 612 712 1
DMR 5126 K4me3 169 52 40 0.03
DMR 5126 H2A.Z 108 47 26 7.80E-06
RNA 2947 K4me3 169 25 23 0.4
RNA 2947 H2A.Z 108 11 15 0.9
K4me3 169 H2A.Z 108 3 1 0.055
chr15M-minus Dataset Gene Overlaps
DMR 9115 RNA 2807 1025 1207 1
DMR 9115 K4me3 2645 1965 1137 8.30E-267
DMR 9115 H2A.Z 128 84 55 1.90E-07
RNA 2807 K4me3 2645 326 350 0.94
RNA 2807 H2A.Z 128 14 17 0.82
K4me3 2645 H2A.Z 128 79 16 1.90E-39
Figure 2. Overlap of dataset gene lists shows effect of altered UBE3A levels on the
epigenome. Size-dependent Venn diagrams show a graphical representation of
the gene lists generated by each genomic assay for each comparison group. Circles
indicate the relative number of genes for each dataset and show the level of over-
lap between datasets within each comparison group.
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chr15M comparison group modeling Dup15q syndrome was
enriched for genes associated with autism, ASD, hypoactivity,
energy expenditure, and obesity (Fig. 3D). Additionally, this
group showed enrichment for genes with functions in ubiqui-
tin-specific protease activity, protein secretion, and protein
import into nucleus. Interestingly, while the KDSH group con-
tained the fewest genes with differential H2A.Z peaks, these
showed highly significant enrichment for imprinted genes
(Fig. 3E). Imprinted genes in this group included IGF2, GNAS,
DKL1, and RTL1 (Supplemental Data). This group also con-
tained genes enriched for epigenetic regulation and fetal
growth. No significant term enrichment was observed for the
KD15M nor the chr15M-minus comparison groups.
Given that several of the comparison groups were enriched for
GO terms related to imprinting, we further evaluated the mode
and extent to which UBE3A affects imprinted genes. We utilized
a list of experimentally confirmed imprinted genes (http://www.
geneimprint.com/site/genes-by-species) and determined the level
of overlap with our datasets within each comparison group. For
all comparison groups, genes with DMRs were significantly
enriched for imprinted genes determined by Fisher’s exact test
(Table 2). Additionally, each comparison group contained
DMRs within known, ubiquitously imprinted ICRs29 (Supple-
mental Data). For the KDSH comparison group, genes with dif-
ferential H2A.Z peaks were also significantly enriched for
imprinted genes including IGF2, GNAS, DLK1, and RTL1.
These four imprinted genes along with non-imprinted EEF2
were also the only five genes to be overlapped between all data-
sets in the KDSH group (Supplemental data). Genes with dif-
ferential H3K4me3 peaks in the chr15M comparison group
also showed significant enrichment for imprinted genes.
We previously demonstrated that SH(15M) cells and
Dup15q brain showed lower levels of the histone H2A ubiqui-
tin ligase RING1B, and genes epigenetically altered in SH(15M)
cells were enriched for higher gene body levels of H2A.Z, a
ubiquitinated target of RING1B.24 To further understand the
connection between UBE3A levels and H2A.Z positioning at
other imprinted genes and genome-wide, we compared levels
of H2A.Z in four quadrants of H2A.Z binding in promoters,
gene bodies, or both (Fig. S9). As expected based on our prior
analysis,24 genes observed to show differential H2A.Z peaks
Figure 3. Gene Ontology enrichment reveals that UBE3A effects epigenetic regulation of neuronal development and imprinted genes. (A) GO enrichment heatmap for
DMR-associated gene lists for each comparison group. Significance of term enrichment by FDR q-value for each group is indicated by colored key. (B) GO enrichment
heatmap for differential H3K4me3-associated gene lists for chr15M, KDSH, and chr15M-minus comparison groups. Significance of term enrichment by FDR q-value for
each group is indicated by colored key. (C) GO enrichment heatmap for differentially expressed genes for each comparison group. Significance of term enrichment by
Bonferroni P value for each group is indicated by colored key. (D) GO enrichment for differential H2A.Z-associated genes in the chr15M comparison group. Significance of
term enrichment by FDR q-value is represented by -log10 bar values. (E) GO enrichment for differential H2A.Z-associated genes in the KDSH comparison group. Signifi-
cance of term enrichment by FDR q-value is represented by -log10 bar values.
Table 2. Genomic datasets imprinted gene overlaps.
Dataset #Genes Imprinted Overlap Expected P value
chr15M Imprinted Gene Overlap
DMR 9778 234 122 108 0.037
RNA 962 234 3 10 1
K4me3 1509 234 24 16 0.046
H2A.Z 406 234 5 4 0.47
KDSH Imprinted Gene Overlap
DMR 7602 234 102 84 8.60E-03
RNA 2557 234 20 28 0.97
K4me3 14457 234 141 159 1
H2A.Z 24 234 4 0 1.30E-04
KD15M Imprinted Gene Overlap
DMR 5126 234 73 56 8.50E-03
RNA 2947 234 31 32 0.61
K4me3 169 234 2 2 0.56
H2A.Z 108 234 0 1 1
chr15M-minus Imprinted Gene Overlap
DMR 9115 234 114 100 4.40E-02
RNA 2807 234 19 31 0.99
K4me3 2645 234 37 29 0.077
H2A.Z 128 234 1 1 0.76
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across all four comparison groups were significantly enriched
for gene body H2A.Z levels compared to all genes (Fig. 4A).
Both SH(15M) cell line conditions showed an approximate 5%
increase in the number of genes with both high promoter and
gene body H2A.Z levels compared to their respective SH-SY5Y
counterparts, which was significant by Fisher’s exact test (P <
0.01). Upon UBE3A knockdown in both cell lines, there was a
significant average 7% loss of genes (both total genes and differ-
ential H2A.Z subset) in the high promoter and gene body H2A.
Z quadrant coinciding with an approximate 7% increase in
genes with low promoter and gene body H2A.Z levels
(Fig. 4A). In contrast, upon UBE3A knockdown in SH-SY5Y,
levels of gene body H2A.Z in EEF2, RTL1, and IGF2 increased
by approximately two-fold compared to the CTL-SH (Fig. 4B
and Fig. S10). As expected based on prior predictions,30 corre-
lating DNA methylation levels with either gene body H2A.Z
(Fig. S10) or promoter H2A.Z (Fig. S11) levels showed a gen-
eral trend of anti-correlation. For both H2A.Z locations, genes
with differential H2A.Z between all comparison groups were
significantly enriched for high gene body DNA methylation
and high H2A.Z levels (quadrant 2) compared to all genes, but
showed no significant changes between cell types or knock-
down conditions. Overall, these data support a model in which
UBE3A levels alter gene body H2A.Z positioning, and suggest
that UBE3A-mediated changes to methylation patterns at
imprinted genes are due, in part, to H2A.Z repositioning partic-
ularly for the lowest UBE3A level (0.1x in KDSH).
Discussion
Our multi-layered genomics analysis of the effect of UBE3A
expression levels in human neuronal cell culture models has
improved the existing evidence for the effect UBE3A has on the
epigenome and resulted in several novel findings. First, our
experiments revealed that both UBE3A gain and loss showed
significant effects on DNA methylation leading to DMRs in
genes involved in transcriptional regulation and brain develop-
ment. Second, we gained new insights into the overlap of dis-
tinct epigenetic marks in response to UBE3A level changes.
Third, these studies revealed a significant effect of knocking
down UBE3A levels on the methylation of up to half of known
imprinted genes, suggesting for the first time a pivotal role for
UBE3A in a neuronal imprinted gene network. Fourth, our
multi-layered approach revealed some interesting new insights
about the degree of overlap between epigenetic marks of gene
activity and transcript levels themselves in a controlled system.
Together, these data give strong support for a genome-wide,
epigenomic function of UBE3A by directing DNA methylation
and H2A.Z positioning and reveal a novel UBE3A-mediated
imprinted gene network in neurons.
Our gene enrichment analyses of UBE3A-mediated changes
to transcripts and epigenetic marks revealed some interesting
insights into the diseases caused by altered UBE3A levels. DMR
analysis revealed genes involved in brain morphology and syn-
aptic vesicle activity as well as genes implicated in ASD-relevant
physiologic deficits including broad face, waddling gait, and
Genu recurvatum. ChIP enrichment for H3K4me3 in the dupli-
cated chromosome comparison groups (chr15M and chr15M-
minus) revealed genes involved in early embryonic and synap-
tic development and behavioral and impaired learning pheno-
types typical to ASD. Differentially expressed genes resulting
from duplication of UBE3A (chr15M) were enriched in neuro-
genesis processes while UBE3A knockdown (KDSH, KD15M,
and chr15M-minus) revealed genes involved in synaptic activ-
ity, stress response, and abnormal imprinting. Most strikingly,
although ChIP enrichment of H2A.Z revealed the fewest genes,
these genes are strongly implicated in autism and a significant
subset are other imprinted genes.
Our data showing significant overlapping genes with
UBE3A-mediated differential methylation and H2A.Z peaks
contributes further understanding to the inter-relationship
between these epigenetic features. We previously observed that
Dup15q patient brain samples showed global DNA hypome-
thylation that was also reflected in the SH(15M) cell line when
compared to the parental SH-SY5Y.24 Additionally, UBE3A
knockdown in both SH-SY5Y and SH(15M) resulted in the res-
toration of synaptic transcripts and RING1B levels but global
DNA methylation levels that remained below those of the con-
trols.24 Here, we identified DMRs that were both hypo- and
hyper-methylated in response to both the 15M effect and
Figure 4. UBE3A knockdown in SH-SY5Y and SH(15M) changes H2A.Z promoter and gene body levels. (A) Percent of genes with high or low promoter H2A.Z and high or
low gene body H2A.Z from quadrants in Figure S5. Percent of total genes and percent of genes with differential H2A.Z peaks are shown for each cell type and siRNA con-
dition. Comparisons indicate significance of the change in number of genes following UBE3A knockdown by Fisher’s exact test. ( P < 0.01,  P < 0.001,  P ffi 0)
(B) Representative UCSC Genome Browser snapshot of IGF2 showing tracks of each genomic dataset and highlighting increase of H2A.Z at imprinted genes.
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differing levels of UBE3A (Figure S5). The hypothesized link
between UBE3A and DNA methylation changes is through
RING1B, an E3 ligase in the human polycomb repressive 1
complex (PRC1).24 RING1B monoubiquitinates H2A and
H2A.Z, and is targeted for canonical ubiquitination and subse-
quent degradation by UBE3A. siRNA studies have shown that
RING1B regulates the overall level of ubiquitinated H2A.Z in
human cells and that monoubiquitinated H2A.Z is associated
with facultative heterochromatin,31 suggesting that H2A.Z
plays a role in epigenetic silencing by holding a poised chroma-
tin state. Furthermore, exclusion of H2A.Z has been seen at
sites of DNA methylation in the bodies of actively transcribed
genes. Mutation of the MET1 DNA methyltransferase causing
both losses and gains of DNA methylation genome-wide have
resulted in reciprocal changes in H2A.Z deposition, while
mutation of the SWR1 complex that incorporates H2A.Z
resulted in genome-wide hypermethylation.30 Additionally,
when DNA methylation is inhibited by azacytidine, H2A.Z-
containing nucleosomes encroach into adjacent regions sug-
gesting that histone variants associated with transcription or
transcriptional poising may be limited to their functional tar-
gets by surrounding DNA methylation marks.32 Together, these
results suggest a role of UBE3A in chromatin changes associ-
ated with altered DNA methylation.
We found that UBE3A knockdown resulted in loss of both
promoter and gene body H2A.Z (Fig. 4A). H2A.Z has different
functions depending on its deposition where presence within
gene bodies is correlated with lower transcription levels and
higher variability in expression patterns across tissue types and
environmental conditions, and a major function of gene-body
DNA methylation is to exclude H2A.Z from the bodies of highly
and constitutively expressed genes.33 Conversely, the incorpo-
ration of monoubiquitinated H2A.Z into specific promoter-
bound nucleosomes configures chromatin structure to poise
genes for transcriptional activation.34 This suggests that H2A.Z
positioning regulates silencing and transcriptional activation via
different mechanisms. While the widespread increase in
H3K4me3 marks at promoters following UBE3A knockdown
has not been previously described, this effect may be a result of
the previously described role for UBE3A in associating with and
polyubiquitinating estrogen receptor.35,36 If UBE3A is required
for degrading ER, the loss of UBE3A molecules likely results in
widespread changes to promoters in which ER should only be
transiently associated following ligand binding.
Through our overlapping datasets, we identified several
imprinted genes affected by UBE3A transcriptionally and epi-
genetically, including DLK1, GNAS, IGF2, and RTL1. UBE3A is
paternally imprinted in post-natal neurons and epigenetic
influences on UBE3A levels in neurons are complex involving
imprinting patterns inherited from oocytes and noncoding
RNAs specific to neurons.18 A network of imprinted genes
including IGF2 and DLK1 has been observed that controls
embryonic growth and may be the basis for the implementation
of a common mechanism of gene regulation during mamma-
lian evolution.15 Additionally, disturbances in the regulation of
imprinted genes have also been found to contribute to pediatric
and adult cancer progression where deregulation of imprinted
genes may be caused by aberrant DNA methylation at the ICRs
controlling expression of individual or clustered imprinted
genes.37,38 This provides evidence that IGNs are pivotal for
proper development and that regulation on an IGN by UBE3A
could be crucial for neurodevelopment specifically.
Our integrated epigenomic assays of UBE3A-mediated
changes led to some somewhat surprising findings with regard
to the lack of significant overlap between transcriptional
changes and genes with altered epigenetics, including
H3K4me3. However, other experiments are consistent with our
findings. For instance, deletion of CFP1 from mESCs causes
loss of most H3K4me3 from expressed CpG island-associated
genes yet there are minimal changes in transcript levels at these
genes, assessed by microarray, or nascent transcription as mea-
sured by levels of RNA polymerase II by ChIP and genomic
run-on sequencing.39 Similarly, deletion of SPP1 from yeast,
resulting in gene-specific H3K4me3 reduction, has virtually no
effect on steady-state or dynamically changing mRNAs or tran-
scription.40 Strikingly, removal of H3K4 trimethylation, the
mark that is most characteristic for transcription, has no effect
on coding gene expression, in steady-state or dynamically
changing conditions. In vitro, H3K4me3 is not required for
transcription of a chromatinized substrate arguing against a
globally instructive role for H3K4me3 in transcription.41
Instead, studies suggest the SET1 histone methyltransferase
complex may rely on pre-existing transcription-dependent
events to deposit H3K4me3 into chromatin, ruling out a strictly
instructive role but explaining the strong correlation with tran-
scription.42–46 The genes that were changed transcriptionally
with UBE3A level changes in our system may have been out of
synchrony with the more direct chromatin and DNA methyla-
tion changes that we observed. Additional studies that integrate
multiple epigenetic marks with transcript changes are needed
to fully understand the inter-relationships.
Here, we have shown the genome-wide, epigenomic effect
on DNA methylation and histone modifications caused by
aberrant levels of neuronal UBE3A. These epigenetic conse-
quences were observed at genes involved in transcriptional reg-
ulation, brain development, as well as other imprinted genes.
Our multi-layered approach also highlighted the disconnect
between epigenetic modifications and transcriptional activity
on a genome-wide scale and provides support that chromatin
marks act as a fingerprint of directed genomic programming
during development and not as an indicator of transient tran-
scriptional changes. Finally, our study identified a novel role of
UBE3A affecting transcription and epigenetics of other
imprinted genes and provides evidence that UBE3A acts as a
regulator in a novel, neuronal IGN. Genome-wide epigenetic
changes related to UBE3A levels were primarily mediated
through changes in H2A.Z deposition and DNA methylation
with consequences on methylation of genes within a novel neu-
ronal imprinted gene network.
Methods
Cell culture, siRNA knockdown, DNA, RNA and protein
isolation
SH-SH5Y and SH-SY5Y-15M [SH(15M)] cells were grown as
described.28 For siRNA knockdown, triplicate cultures of SH
and SH15M cells were transfected in Accell SMARTpool
EPIGENETICS 987
transfection medium containing 1 mM of UBE3A or control
siRNAs supplemented with 2.5% fetal bovine serum for 5 days.
siRNA-mediated knockdown of UBE3A protein was carried
out using the Accell SMARTpool (Dharmacon L-005137-00-
0005) mixture of four siRNAs according to the manufacturer’s
protocols. Accell non-targeting siRNA (Dharmacon D-001810-
10-05) was used in knockdown controls. Briefly, approximately
400,000 SH or SH15M cells were plated in 12-well plates
(DNA, RNA, and protein extraction) or approximately 5 £ 10⁶
cell in 10 cm dishes (ChIP) and then incubated for 72 h in
serum-free Accell SMARTpool transfection medium contain-
ing 1 mM of UBE3A siRNAs or non-target control. After 72 h,
the medium was supplemented with serum-containing media.
The cells were incubated for an additional 48 h for a total of
five days. UBE3A knockdown was confirmed by Western blot
analysis. DNA was isolated using the Zymo Quick-gDNA Min-
iPrep Kit. RNA was isolated using the Qiagen RNeasy Mini Kit.
Protein was isolated using Thermo Fisher RIPA Lysis and
Extraction Buffer and centrifugation.
Western blot
Protein extracts (20–50 mg) were subjected to 4–20% precast
polyacrylamide gel (Bio-rad). The samples were separated and
transferred onto PVDF membranes for 130 min at a constant
current of 100 mA. The membranes were blocked in TBS block-
ing buffer containing 5% non-fat dried milk for 1 h.
Anti-E6AP (1:1,000, Bethyl laboratory, A300-352A) and anti-
GAPDH (1:10,000, Advanced Immunochemical, Inc., 2-RGM2)
were incubated with the membranes in blocking buffer contain-
ing 0.1% Tween and 5% non-fat dried milk overnight at 4C.
The membranes were then washed and incubated with horserad-
ish peroxidase conjugated secondary antibodies, anti-mouse (Bio
Rad, 170–5047) and anti-rabbit (Bio Rad, 170–6515) immuno-
globulin (IgG) antibody in 1:10,000 dilution for 1 h. After mem-
brane washing, bound antibody was detected using a Super
Signal West Dura Extended Duration Substrate kit (Thermo
Fisher Scientific Inc.). Protein bands were normalized according
to GAPDH using the ImageJ densitometry analysis system.
ChIP sample preparation
Following siRNA knockdown, cells were cross-linked by adding
formaldehyde to a final concentration of 1% and incubated at
RT for 10 min. Cross-link reaction was stopped by adding gly-
cine to a final concentration of 0.125 M and incubated at RT
for 5 min. Cells were rinsed twice with 1X PBS and, scraped,
and pelleted. Pellets were resuspended in 200 uL 5 mM PIPES
pH 8.0, 85 mM KCL with 10 uL IGEPAL and 10 uL PMSF pro-
tease inhibitor cocktail and incubated on ice for 10 min. Sam-
ples were briefly vortexed to release nuclei and centrifuged to
pellet nuclei. Nuclei were then resuspended in 100 uL 50 mM
Tris-HCl pH 8.1, 10 mM EDTA, 1% SDS with 10 uL PMSF and
incubated on ice for 10 min. Chromatin was sheared on a
Covaris E220 to an average length of 600 bp. Total chromatin
(5%) was saved as input control and remaining chromatin was
diluted 1:3 in 1 M Tris-HCl pH 8.1, 0.5 M EDTA, 5 M NaCl,
1.1% Trition X100, 0.01% SDS, and incubated with H3K4me3
antibody (Active Motif 39159) or H2A.Z antibody (Active
Motif 39113) on a rotating platform at 4C overnight. Magnetic
protein G beads (15 ml; Cell Signaling Technology 9006) were
added to each sample and incubated on a rotating platform for
2 h at 4C. Magnetic beads were washed with RIPA buffer then
settled in a magnetic rack followed by washes with 100 mM
Tris-HCl pH 9.0, 500 mM LiCl, 1% IGEPAL, 1% deoxycholic
acid then 100 mM Tris-HCl pH 9.0, 500 mM LiCl, 1% IGEPAL,
1% deoxycholic acid, 150 mM NaCl, respectively. Antibody/
chromatin complexes were eluted with 100 uL 50 mM
NaHCO3, 1% SDS. A total of 12 uL of 5 M NaCl was added
and samples were incubated at 67C overnight to reverse cross-
links. Samples were cooled and 1 uL RNaseA was added and
incubated at 37C for 30 min. DNA was purified using the Qia-
gen QIAquick PCR Purification Kit.
WGBS, RNA-seq, and ChIP-seq library preparation
WGBS libraries were prepared using the Illumina TruSeq DNA
Methylation Kit (Illumina EGMK81312) according to manu-
facturer’s protocol and three samples were pooled per lane on
the HiSeq4000. RNA-seq libraries were prepared using the
NEB NEBNext rRNA Depletion Kit (NEB E6310L) and NEB-
Next Ultra Directional RNA Library Prep Kit for Illumina
(NEB E7420S) according to manufacturer’s protocol and six
samples were pooled per lane on the HiSeq4000. NGS libraries
from ChIP DNA samples and input control DNA were pre-
pared using the Kapa Biosystems KAPA Hyper Prep Kit (Kapa
KK8504) according to manufacturer’s protocol and 12 samples
were pooled per lane on the HiSeq4000.
Bioinformatics
For all samples raw FASTQ files were filtered and trimmed
using Trimmomatic.47 For WGBS, reads were aligned to the
human genome (hg38) using BS-Seeker2.48 DMRs were called
using the R packages DSS and bsseq and custom R com-
mands.49,50 For RNA-seq, reads were aligned to hg38 using
TopHat2.51 Differentially expressed genes were calculated using
the edgeR Bioconductor package.52,53 For ChIP-seq, reads were
aligned using Bowtie2.54 ChIP peaks and differential peaks
were called using MACS2.55 Gene Ontology was analyzed using
GREAT56 for DMRs, H3Kme3, and H2A.Z gene lists, and
Enrichr57,58 for DE genes lists.
Differentially methylated region analysis
All custom scripts and code are available for download at
github.com/kwdunaway/WGBS_Tools as well as instructions
on how to use them. Brief descriptions of each script are also
on the wiki of this site.
Data access
All sequencing data were deposited in the Gene Expression
Omnibus (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE103309), accession number GSE103309. The authors
declare no competing financial interests. Correspondence and
requests for materials should be addressed to JML
(jmlasalle@ucdavis.edu).
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